YZYi-Tian Zhu

Yi-Tian Zhu

*This is an algorithmically generated author record based on publicly available information.

Yi-Tian Zhu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Lan-Lan Xiang

    Department of Clinical Laboratory, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China

    2 shared publications
  • Shu-Yu Li

    Department of Clinical Laboratory, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China

    2 shared publications
  • Tianying Zhong

    Department of Clinical Laboratory, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China

    2 shared publications
  • Yi-Ting Chen

    Department of Clinical Laboratory, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China

    2 shared publications
  • Yu Zeng

    Department of Clinical Laboratory, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China

    2 shared publications
  • Mei-Mei Hu

    Department of Clinical Laboratory, Women's Hospital of Nanjing Medical University, Nanjing Women and Children's Healthcare Hospital, Nanjing, China

    1 shared publication

Latest Publications

  • Top Cited Papers
    Open Access

    Early-pregnancy remnant cholesterol as a modifiable risk factor for gestational diabetes mellitus

    by Mei-Mei Hu, Shu-Yu Li, Lan-Lan Xiang, Yi-Tian Zhu, Yi-Ting Chen, Yun Liu, Ya-Jun Chen, Yu Zeng, Tian-Ying Zhong


  • Open Access

    Predictive Value of the second-Trimester Triglyceride-Glucose Index and Its Derived Indices for Macrosomia in Gestational Diabetes Mellitus

    by Yiting Chen, Shuyu Li, Lanlan Xiang, Yitian Zhu, Yu Zeng, Yajun Chen, Tianying Zhong

    Background: Macrosomia is a major adverse outcome associated with gestational diabetes mellitus (GDM), primarily driven by insulin resistance (IR). The triglyceride-glucose (TyG) index is a well-established surrogate marker for insulin resistance; however, its predictive value when combined with obesity indicators remains incompletely defined. This study aimed to compare the predictive performance of the TyG index and its derived indices during the second trimester for the risk of macrosomia in GDM. Methods: The TyG index, TyG body mass index (TyG-BMI), TyG waist circumference (TyG-WC), and TyG waist-to-height ratio (TyG-WHtR) were assessed at 24– 28 weeks of gestation. Their associations with macrosomia were analyzed using binary logistic regression and restricted cubic spline (RCS) analysis. The predictive performance of these indices was compared using receiver operating characteristic (ROC) curves, integrated discrimination improvement (IDI), and net reclassification improvement (NRI). The associations between TyG and its derived indices and the risk of delivering a macrosomic infant were further explored across different subgroups. Results: Logistic regression revealed that GDM women in the highest tertile had a 3.458- and 3.718-fold higher risks of delivering macrosomia compared to the lowest tertile for TyG-BMI and TyG-WC, respectively. RCS analysis showed a dose-response relationship (all P for overall < 0.001). Compared with the conventional TyG index, which had an area under the curve (AUC) of 0.596, both TyG-BMI (AUC = 0.682) and TyG-WC (AUC = 0.681) demonstrated significantly better performance (P < 0.01); furthermore, their superiority was confirmed by significant IDI and NRI values (P < 0.01). The association was more pronounced in primiparous women aged < 35 years (P < 0.05). Conclusion: Elevated second-trimester TyG index and its derived indices are associated with an increased risk of macrosomia in GDM women. TyG-BMI and TyG-WC outperformed the conventional TyG index and may serve as valuable supplementary markers for early risk stratification in GDM.